Trials / Recruiting
RecruitingNCT06274645
IVUS CHIP China Registry
Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures China Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,020 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about in patients with complex coronary lesions undergoing PCI. The main question\[s\] it aims to answer are: the clinical efficacy and safety of an IVUS-guided approach in patients with complex coronary lesions undergoing PCI, as well as clinical outcomes up to 2 years. Participants will be treated with IVUS-guided PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The OptiCross High Definition (60 MHz) and OptiCross (40MHz) Intravascular Ultrasound (IVUS) catheter from Boston Scientific | The IVUS-guided PCI procedure includes the use of IVUS before PCI (highly recommended) and after PCI (mandatory) |
Timeline
- Start date
- 2024-03-12
- Primary completion
- 2026-07-01
- Completion
- 2028-02-01
- First posted
- 2024-02-23
- Last updated
- 2024-04-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06274645. Inclusion in this directory is not an endorsement.